Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Overweight × Exenatide × Clear all

Phase

Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sexual Infantilism 1 Polycystic Ovary Syndrome 1 Overweight 1 Obesity 1 Insulin Resistance 1 Craniopharyngioma 1

Interventions

licogliflozin 1 bupropion hydrochloride, naltrexone hydrochoride drug combination 1 Naltrexone 1 Exercise 1 Exenatide 1 Diet, Plant-Based 1 Counseling 1 Bupropion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01484873 2017-03-03

Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor

Vanderbilt University Medical Center

Phase 2 Completed

10 enrolled 15 charts

Craniopharyngioma, Obesity, Sexual Infantilism, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon ⚡